13th RWE, MARKET ACCESS, PRICING & REIMBURSEMENT World Congress 2026 Europe
Powering Market Access Through Real-World Evidence, Digital Innovation & Value-Based Strategies
Thursday 3rd - Friday 4th September 2026 - Hilton London Kensington, London, UK
2026 Key Industry Expert Speakers
Antonella Cardone
CEO
Antonella Cardone is the CEO of Cancer Patients Europe, a pan-European all-cancer patient association. She is a Patient Advocacy Expert and Advisor to the Board of Pancreatic Cancer Europe (PCE), uniting physicians, patients, politicians, journalists, academia, and industry, and she is a member of Inspire2Live.
Antonella led the European Cancer Patient Coalition (ECPC) and served as Executive Director of the Fit for Work Global Alliance.
With 25 years of nonprofit experience in health, social, and employment sectors, she also directed the Global Smoke-free Partnership of the American Cancer Society.
Antonella holds Master's degrees in Science and Business Administration. She has been on the Boards of All.Can and Pancreatic Cancer Europe, where she was vice-chair.
Professor James Levine MD PhD
President
Dr. Levine has three decades of experience in the healthcare sector at Mayo Clinic. For the last 5 years he has been President of Fondation Ipsen, an international science foundation focused on Rare Disease innovation.
With a background in wearable technologies, data gathering and data analytics, and with more than 100 patents and trademarks, Levine helped found 35 companies (17 to Series A and 1 IPO). He was the Innovator of the Year in the state of Minnesota, the World Trade Fair and NASA. Under the Mayo Clinic NEAT Trademarks Levine’s team delivered scalable health solutions to 72 US corporations.
A great deal of James’ work focuses on biotech development, scalable health solutions and business opportunities in underserved countries. The UNESCO World Report on Science which he sponsored in his current role, facilitated business development (without personal gain) in underserved regions in the United States, and in the Democratic Republic of Congo (DRC), Cote d’Ivoire, Afghanistan, Jamaica, Asia, Kenya and India. Consulting to four USA Presidents, the State Department, US Army and internationally, Levine in 2018 was awarded the President’s Medal for promoting social embeddedness.
A physician and scientist, Levine has published more than 200 articles, six papers in Science and Nature plus articles in journals such as, the New England Journal of Medicine, Lancet and JAMA. He has written four books published in 19 languages in 37 countries. 300 million people live with rare diseases without effective cures. Sustainable solutions require the efficient use of capital to maximize impact and minimize suffering.
Marta Contente
Sr Director, Pipeline Head of Immunology
Marta is currently the Immunology Pipeline Head at TEVA, where she leads the Immunology Global HEVO team. She oversees the strategic direction of the Global Value Teams and is responsible for enhancing the focus on value assessment and payer needs for pipeline assets.
Before joining TEVA, Marta was a Senior Director of Global Health Economics and Outcomes Research at Bristol Myers Squibb (BMS). She led a team responsible for supporting country HTA submissions and access for Cardiology, Immunology and Neuroscience products. Her responsibilities covered all countries outside of the US. Before this role Marta worked within the BMS global HEOR team across Oncology indications and at the Portuguese affiliate across company portfolio (Virology, Metabolics, Haem and Oncology) Previously to BMS, Marta worked at GSK and Pfizer as Market Access manager (Portugal), as well as at Lundbeck in Global Pricing.
Marta holds a degree in Pharmaceutical Sciences from Lisbon University, a Postgraduate Diploma in Health Economics from University of York and an Executive MBA from AESE - IESE Business School
